RYTM

RhythmD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Current thesis

Composite grade D from latest DB weights. Momentum 40.9 / Value 41.1

Posture

Defensive

Lead driver

Momentum

What changed

Momentum remains the lead driver in the composite, 7D delta +3.2.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

0 · Net Neutral

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-06-02

Fundamentals

As of 2026-06-01 • Vendor: Data Vendor v1

Scores

As of 2026-06-02 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-06-02

Supporting evidence

What

Grade D · Defensive

Confidence Medium · Net Neutral

Target $139.67

Why

Momentum41 · Δ7d +3.2

Value41 · Δ7d +0.1

SentimentN/A · Δ7d -

So what

Weak posture (Net Neutral). Prioritize risk control and patience.

Lead driver: Momentum · See technicals

Momentum

52% active weight

Current posture

7d trendSoftening

Δ7d

+3.2

Δ21d

+20.2

Value

48% active weight

Current posture

7d trendFlat

Δ7d

+0.1

Δ21d

+0.2

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade D. Momentum 40.9 / Value 41.1

Fundamentals (TTM)

As of 2026-06-01

Market Cap

$6.03B

Beta

2.01

Shares Out

66.74M

P/E (TTM) · Derived

-29.1

P/S (TTM)

38.99

P/FCF (TTM) · Derived

-52.68

Rev YoY

+54.3%

EPS YoY

-11.5%

Gross Margin

+89.4%

Op Margin

-106.8%

Net Debt

-$210.76M

Current Ratio

4.75

As of 2026-06-02 • Updated nightlySource: Internal modelMethodology